Robert Olstein
Olstein Capital Management
Robert Olstein Axalta Coating Systems Ltd stake
total: 342
Olstein Capital Management AXTA trades
- Total transactions:
- 26
- New positions:
- 1
- Sold out:
- 1
- Added:
- 12
- Reduced:
- 12
- Held since:
- 2017 Q1
- Held for:
- 31 quarters
- Latest activity:
- 2024 Q4
According to 2026 Q2 report, Robert Olstein doesn't hold any Axalta Coating Systems Ltd (AXTA) shares. To date, the estimated cost basis is nearly $28.67 for "buy" trades and estimated average "sell" price is $32.27. Olstein Capital Management first purchased AXTA in 2017 Q1, initially acquiring 241,940 shares. Since the initial investment in Axalta Coating Systems Ltd (AXTA), Olstein Capital Management has made 25 more transactions.
When did Robert Olstein sell Axalta Coating Systems Ltd (AXTA)?
Robert Olstein sold off the entire Axalta Coating Systems Ltd (AXTA) position in 2024 Q4.
When did Robert Olstein buy Axalta Coating Systems Ltd (AXTA)?
Robert Olstein first invested in Axalta Coating Systems Ltd (AXTA) in 2017 Q1 at the reported quarter-end price of $32.20 per share.
What's the cost basis of Olstein Capital Management's AXTA stake?
The estimated cost basis for Axalta Coating Systems Ltd (AXTA) stake is around $28.67 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $28.67
- Weighted AVG sell price:
- $32.27
Robert Olstein's historical trades in Axalta Coating Systems Ltd
26 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$36.19
|
|
-100% (-103,000)
|
-0.63%
|
|
2024 Q2
|
0.63%
|
103,000
|
$34.17
|
$3,520,000
|
-25.96% (-36,105)
|
-0.2%
|
|
2023 Q4
|
0.80%
|
139,105
|
$33.97
|
$4,725,000
|
-43.68% (-107,895)
|
-0.63%
|
|
2023 Q3
|
1.14%
|
247,000
|
$26.90
|
$6,644,000
|
+28.65% (+55,000)
|
+0.25%
|
|
2023 Q2
|
1.02%
|
192,000
|
$32.81
|
$6,300,000
|
-13.90% (-30,997)
|
-0.16%
|
|
2023 Q1
|
1.06%
|
222,997
|
$30.29
|
$6,755,000
|
-31.48% (-102,453)
|
-0.49%
|
|
2022 Q3
|
1.15%
|
325,450
|
$21.06
|
$6,854,000
|
+2.84% (+9,000)
|
+0.03%
|
|
2022 Q2
|
1.05%
|
316,450
|
$22.11
|
$6,997,000
|
+9.42% (+27,250)
|
+0.09%
|
|
2022 Q1
|
0.89%
|
289,200
|
$24.58
|
$7,109,000
|
+1.65% (+4,700)
|
+0.01%
|
|
2021 Q4
|
1.12%
|
284,500
|
$33.12
|
$9,423,000
|
-3.07% (-9,000)
|
-0.04%
|
|
2021 Q3
|
1.05%
|
$29.19
|
+13.45% (+34,800)
|
|||
|
2021 Q2
|
0.99%
|
$30.49
|
+4.09% (+10,163)
|
|||
|
2021 Q1
|
1.03%
|
$29.58
|
+8.75% (+20,000)
|
|||
|
2020 Q4
|
1.04%
|
$28.55
|
-4.38% (-10,463)
|
|||
|
2020 Q3
|
0.96%
|
$22.17
|
-0.42% (-1,000)
|
|||
|
2020 Q2
|
1.01%
|
$22.55
|
-2.83% (-7,000)
|
|||
|
2020 Q1
|
0.94%
|
$17.27
|
+13.82% (+30,000)
|
|||
|
2019 Q3
|
1.02%
|
$30.15
|
-2.69% (-6,000)
|
|||
|
2019 Q2
|
1.08%
|
$29.77
|
+1.46% (+3,200)
|
|||
|
2019 Q1
|
0.91%
|
$25.21
|
-17.28% (-45,900)
|
|||
|
2018 Q4
|
1.02%
|
$23.42
|
+19.26% (+42,901)
|
|||
|
2018 Q3
|
0.87%
|
$29.16
|
-3.76% (-8,700)
|
|||
|
2018 Q1
|
0.89%
|
$30.19
|
+0.23% (+540)
|
|||
|
2017 Q4
|
0.95%
|
$32.36
|
-6.86% (-17,000)
|
|||
|
2017 Q2
|
1.01%
|
$32.04
|
+2.49% (+6,019)
|
|||
|
2017 Q1
|
1.00%
|
$32.20
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.